|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller DC, Hafez KS, Stewart A, Montie JE
and Wei JT: Prostate carcinoma presentation, diagnosis, and
staging: An update form the National Cancer Data Base. Cancer.
98:1169–1178. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang SQ, Mecca PS, Myskowski PL and Slovin
SF: Scrotal and penile papules and plaques as the initial
manifestation of a cutaneous metastasis of adenocarcinoma of the
prostate: Case report and review of the literature. J Cutan Pathol.
35:681–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar S, Shelley M, Harrison C, Coles B,
Wilt TJ and Mason MD: Neo-adjuvant and adjuvant hormone therapy for
localized and locally advanced prostate cancer. Cochrane Database
Syst Rev. 18:CD0060192006.
|
|
8
|
Gleason DF and Mellinger GT: Prediction of
prognosis for prostatic adenocarcinoma by combined histological
grading and clinical staging. J Urol. 111:58–64. 1974.PubMed/NCBI
|
|
9
|
Parwani AV, Marlow C, Demarzo AM,
Mikolajczyk SD, Rittenhouse HG, Veltri RW and Chan TY:
Immunohistochemical staining of precursor forms of
prostate-specific antigen (proPSA) in metastatic prostate cancer.
Am J Surg Pathol. 30:1231–1236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kessler ER and Flaig TW: Geriatric
considerations in the treatment of advanced prostate cancer. F1000
Prime Rep. 6:332014.
|
|
11
|
Antczak A, Kluźniak W, Wokolorczyk D,
Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dębniak
T and Masojć B: A common nonsense mutation of the BLM gene and
prostate cancer risk and survival. Gene. 532:173–176. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cortesi M, Fridman E, Volkov A, Shilstein
SSh, Chechik R, Breskin A, Vartsky D, Raviv G and Ramon J: New
prospective for non-invasive detection, grading, size evaluation
and tumor location of prostate cancer. Prostate. 70:1701–1708.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bubendorf L, Schöpfer A, Wagner U, Sauter
G, Moch H, Willi N, Gasser TC and Mihatsch MJ: Metastatic patterns
of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol.
31:578–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johansson JE and Lannes P: Metastases to
the spermatic cord, epididymis and testicles from carcinoma of the
prostate-five cases. Scand J Urol Nephrol. 17:249–251. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pienkos EJ and Jablokow VR: Secondary
testicular tumors. Cancer. 30:481–485. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thon W, Mohr W and Altwein JE: Testicular
and epididymal metastasis of prostate cancer. Urologe A.
24:287–290. 1985.(In German). PubMed/NCBI
|
|
17
|
Tu SM, Reyes A, Maa A, Bhowmick D, Pisters
LL, Pettaway CA, Lin SH, Troncoso P and Logothetis CJ: Prostate
carcinoma with testicular or penile metastases. Clinical,
pathologic and immunohistochemical features. Cancer. 94:2610–2617.
2002. View Article : Google Scholar : PubMed/NCBI
|
